81
Participants
Start Date
May 31, 2013
Primary Completion Date
December 31, 2014
Study Completion Date
March 31, 2015
TOOKAD® Soluble
The VTP procedure will consist of a single, 10 minute infusion of 4mg/kg TOOKAD® Soluble. The drug will be activated by laser light at 753nm, with a fixed energy of 200Joules/cm, and a fixed power of 150mWatts/cm, delivered through transperineal interstitial optical fibers. The needles are positioned in the prostate under ultra sound image guidance.
Hospital General Tlahuac, Mexico City
Pan-American Medical Research Institute (PAMRI) then moved to Consultario del Dr Rodriguez, Panama City
Hospital Nacional Cayetano Heredia, San Martín de Porres
Steba Biotech S.A.
OTHER